ARWR
Price
$32.80
Change
+$1.13 (+3.57%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
4.53B
65 days until earnings call
OLMA
Price
$9.51
Change
+$1.32 (+16.12%)
Updated
Sep 26 closing price
Capitalization
652.71M
45 days until earnings call
Interact to see
Advertisement

ARWR vs OLMA

Header iconARWR vs OLMA Comparison
Open Charts ARWR vs OLMABanner chart's image
Arrowhead Pharmaceuticals
Price$32.80
Change+$1.13 (+3.57%)
Volume$40.51K
Capitalization4.53B
Olema Pharmaceuticals
Price$9.51
Change+$1.32 (+16.12%)
Volume$1.41M
Capitalization652.71M
ARWR vs OLMA Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. OLMA commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a StrongBuy and OLMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ARWR: $32.80 vs. OLMA: $9.51)
Brand notoriety: ARWR: Notable vs. OLMA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 74% vs. OLMA: 164%
Market capitalization -- ARWR: $4.53B vs. OLMA: $652.71M
ARWR [@Biotechnology] is valued at $4.53B. OLMA’s [@Biotechnology] market capitalization is $652.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while OLMA’s TA Score has 5 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 3 bearish.
  • OLMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а +6.88% price change this week, while OLMA (@Biotechnology) price change was +16.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ARWR is expected to report earnings on Dec 01, 2025.

OLMA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($4.54B) has a higher market cap than OLMA($653M). ARWR YTD gains are higher at: 74.441 vs. OLMA (63.122). ARWR has higher annual earnings (EBITDA): -52.51M vs. OLMA (-156.66M). ARWR has more cash in the bank: 900M vs. OLMA (362M). OLMA has less debt than ARWR: OLMA (4.76M) vs ARWR (353M). ARWR has higher revenues than OLMA: ARWR (573M) vs OLMA (0).
ARWROLMAARWR / OLMA
Capitalization4.54B653M694%
EBITDA-52.51M-156.66M34%
Gain YTD74.44163.122118%
P/E RatioN/AN/A-
Revenue573M0-
Total Cash900M362M249%
Total Debt353M4.76M7,424%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWROLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVSVX19.890.17
+0.86%
Third Avenue Small Cap Value Investor
AGTIX171.400.50
+0.29%
AB Sustainable Global Thematic I
FBCVX24.53N/A
N/A
Fidelity Blue Chip Value
OPTIX113.47N/A
N/A
Invesco Discovery Large Cap R6
LIONX10.09N/A
N/A
Issachar N

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+3.58%
DNLI - ARWR
52%
Loosely correlated
+3.87%
IMNM - ARWR
50%
Loosely correlated
+14.13%
IPSC - ARWR
48%
Loosely correlated
+4.41%
CRNX - ARWR
48%
Loosely correlated
+27.92%
RGNX - ARWR
47%
Loosely correlated
+3.10%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+16.12%
IDYA - OLMA
46%
Loosely correlated
+4.44%
ATXS - OLMA
44%
Loosely correlated
+2.10%
ARWR - OLMA
44%
Loosely correlated
+3.60%
EYPT - OLMA
44%
Loosely correlated
+5.38%
CRNX - OLMA
43%
Loosely correlated
+27.92%
More